Preparing for the worst

 - radiation dose
Twitter icon
Facebook icon
LinkedIn icon
e-mail icon
Google icon

As we approach the summer season of doomsday movies in all their cinematic gore-y, it may be no surprise that nuclear catastrophe enters into a few imaginations. But at the FDA, it is science and not science fiction that is under discussion as the agency reviews an animal study on Amgen’s leukocyte growth factors as a nuclear countermeasure. The FDA will discuss whether a human study is warranted on May 3. The Bloomberg article includes a link to the FDA backgrounder.